15/02/2024 12:28 (UTC)

Drug identified that blocks the action of key Parkinson's disease cells

Barcelona, Feb 15 (EFE) - A group of researchers has identified that a drug used for autoimmune diseases is potentially useful for blocking the action of brain cells, and astrocytes, which are key in the development of Parkinson's disease.

Scientists from the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Biomedicine of the University of Barcelona (IBUB), in collaboration with neurologists from Hospital Clínic, have demonstrated that in Parkinson's astrocytes are reactive, so that they attack and kill the nerve cells that produce dopamine.

FOOTAGE OF THE BIOMEDICAL RESEARCH INSTITUTE OF BELLVITGE (IDIBELL)

Metadata

Date: 15/02/2024 12:23 (UTC)
Credit: EFE
Source: EFE
Topic: Science and technology
Type: Rough cut
Duration: 242 seconds
Reference: 7001336615
Relevance: Normal